Electromed (NYSE:ELMD) Now Covered by Analysts at B. Riley

B. Riley assumed coverage on shares of Electromed (NYSE:ELMD) in a report issued on Thursday, Marketbeat reports. The firm issued a buy rating and a $38.00 price objective on the stock.

Separately, StockNews.com cut Electromed from a “strong-buy” rating to a “buy” rating in a research note on Wednesday.

Electromed Trading Down 2.5 %

NYSE ELMD opened at $28.63 on Thursday. Electromed has a 12 month low of $13.74 and a 12 month high of $35.56. The stock has a 50-day simple moving average of $31.40 and a 200 day simple moving average of $25.17. The company has a market capitalization of $245.07 million, a PE ratio of 38.17 and a beta of 0.33.

Insider Activity

In other news, Director Andrew Summers sold 17,463 shares of Electromed stock in a transaction dated Monday, December 2nd. The stock was sold at an average price of $30.09, for a total transaction of $525,461.67. Following the transaction, the director now owns 189,838 shares in the company, valued at $5,712,225.42. The trade was a 8.42 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Kathleen Skarvan sold 38,954 shares of the business’s stock in a transaction that occurred on Tuesday, February 18th. The shares were sold at an average price of $29.28, for a total value of $1,140,573.12. Following the completion of the transaction, the director now owns 32,622 shares of the company’s stock, valued at $955,172.16. This represents a 54.42 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 77,788 shares of company stock valued at $2,326,350 in the last quarter. Company insiders own 14.00% of the company’s stock.

Institutional Investors Weigh In On Electromed

Large investors have recently made changes to their positions in the stock. Ritholtz Wealth Management acquired a new position in Electromed in the 4th quarter worth $488,000. Barclays PLC bought a new stake in shares of Electromed in the third quarter valued at about $215,000. Navellier & Associates Inc. acquired a new position in shares of Electromed during the third quarter worth about $368,000. State Street Corp boosted its position in shares of Electromed by 14.5% during the third quarter. State Street Corp now owns 22,066 shares of the company’s stock worth $474,000 after buying an additional 2,800 shares during the period. Finally, Walleye Capital LLC bought a new position in shares of Electromed during the third quarter worth about $274,000. Institutional investors own 40.82% of the company’s stock.

Electromed Company Profile

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions.